Live Breaking News & Updates on Pharmaceutics Building|Page 3

Stay updated with breaking news from Pharmaceutics building. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NLS Pharmaceutics AG: NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds

Management to Discuss Pipeline Goals and Development Strategies across four Preclinical and 2 Clinical Programs across Multiple Central Nervous System (CNS) DisordersNLS to Webcast its R&D Day Event Tuesday ....

Marianne Lambertson , European Patent Office , Pharmaceutics Ltd View , Company Rd Day , International Patent Application No , Pharmaceutics Ltd , Exchange Commission , Development Strategies , Discuss Pipeline Goals , Multiple Central Nervous System , Drug Designation , International Patent Application , Kleine Levin Syndrome , Lewy Bodies , Parkinson Disease , Lewy Body Disease , Ltd View ,

NLS Pharmaceutics AG: NLS Pharmaceutics to Participate in Upcoming Investor Conferences

ZURICH, SWITZERLAND / ACCESSWIRE / January 11, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and ....

Alex Zwyer , Marianne Lambertson , Pharmaceutics Ltd , Chief Executive Officer , One Partnering , Annual Roth , Annual Roth Conference ,

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Technology Patent Grant Covering Mazindol for Treatment of Attention Deficit Hyperactivity Disorder and Rare Sleep Disorders in Hong Kong

Hong Kong patent relates to Company's lead product candidate, Mazindol ER (extended-release) use in narcolepsy, idiopathic hypersomnia (IH) and attention deficit hyperactivity disorder (ADHD)Further supports ....

Hong Kong , South Korea , Alex Zwyer , Marianne Lambertson , Exchange Commission , Property Department , Pharmaceutics Ltd View , European Medicines Agency , Drug Administration , Pharmaceutics Ltd , Patents Registry , Intellectual Property Department , Hong Kong Special Administrative Region , Patent Application , Chief Executive Officer , Orphan Drug Designations , Mainland China , Market Data Forecast , Orphan Disease Designation , Mazindol Controlled Release , Ltd View ,

NLS Pharmaceutics AG: NLS Pharmaceutics CEO Issues Letter to Shareholders

ZURICH, SWITZERELAND / ACCESSWIRE / December 22, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery ....

United Kingdom , Eric Konofal , Alex Zwyer , Astrid Sommer , Versantis Genfit , George Apostol , Marianne Lambertson , Tom Curatolo , Endo Pharmaceuticals Inc , Operations For Ironshore Pharmaceuticals , Shire Pharmaceuticals , Drug Administration , Pharmaceutics Ltd , Exchange Commission , Global Head Of Research , Caligor Coghlan Pharma Services , Head Of Corporate Communications Investors Relations , Patient Program , Chief Executive Officer , Central Nervous System , Open Label Extension , New Drug Application , Named Patient Program , Marcus Ventures , Chad Hellmann , Chief Medical Officer ,

NLS Pharmaceutics AG: NLS Pharmaceutics Announces Israeli Patent Grant Covering Mazindol for Treatment of Attention Deficit Hyperactivity Disorder and Other Sleep Disorders Through 2037

Israeli patent relates to Mazindol use in attention deficit hyperactivity disorder (ADHD) or related arousal deficits (i.e., uncontrollable sleepiness), use in the treatment of reduced alertness (daytime ....

Alex Zwyer , Marianne Lambertson , Maccabi Healthcare Services , Exchange Commission , European Medicines Agency , Israeli Patent Office , Drug Administration , Pharmaceutics Ltd , Patent Application , Hyperactivity Disorder , Chief Executive Officer , Market Data Forecast , Orphan Disease Designation , Mazindol Controlled Release , Orphan Drug Designations ,